Literature DB >> 35139870

Correction to: ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells.

Bailing Zu1, Yi Shi2, Min Xu1, Guoling You3, Zhenglan Huang1, Miao Gao1, Wenli Feng4.   

Abstract

Entities:  

Year:  2022        PMID: 35139870      PMCID: PMC8827258          DOI: 10.1186/s13046-022-02279-4

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


× No keyword cloud information.
Correction to: J Exp Clin Cancer Res 34, 56 (2015) https://doi.org/10.1186/s13046-015-0139-4 Following publication of the original article [1], the authors identified a minor error in Figure 4, specifically:
Fig. 4

Immunofluorescent staining to measure SUZ12 in BP-CML cells with an ARE/SUZ12-regulated TK/GCV system. CML blast crisis cells were transduced with PBS, Ad-AS-TK, or empty adenovirus, and cultured in 100 μmol/l GCV for 48 h

Fig. 4: incorrect immunofluorescent staining image used to represent KCL22 Ad-empty control (2nd row, 2nd column); the image has been replaced with the correct image The corrected figure is given here. The correction does not have any effect on the final conclusions of the paper. Immunofluorescent staining to measure SUZ12 in BP-CML cells with an ARE/SUZ12-regulated TK/GCV system. CML blast crisis cells were transduced with PBS, Ad-AS-TK, or empty adenovirus, and cultured in 100 μmol/l GCV for 48 h
  1 in total

1.  ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells.

Authors:  Bailing Zu; Yi Shi; Min Xu; Guoling You; Zhenglan Huang; Miao Gao; Wenli Feng
Journal:  J Exp Clin Cancer Res       Date:  2015-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.